[an error occurred while processing this directive]
中华放射肿瘤学杂志
   2025年4月10日 星期四     首 页 |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告合作  |  学术影响  |  收录情况  |  联系我们  |  English
中华放射肿瘤学杂志  2023, Vol. 32 Issue (3): 194-200    DOI: 10.3760/cma.j.cn113030-20211103-00451
头颈部肿瘤 最新目录| 下期目录| 过刊浏览| 高级检索 [an error occurred while processing this directive]|[an error occurred while processing this directive]
下咽合并第二原发性肿瘤的临床特征及疗效分析:216例真实世界研究
罗希1, 吴润叶1, 刘绍严2, 王晓雷2, 倪晓光3, 张烨1, 黄晓东1, 王凯1, 陈雪松1, 王静波1, 张江鹄1, 曲媛1, 罗京伟1, 易俊林1
1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科,北京 100021;
2国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院头颈外科,北京 100021;
3国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院内镜科,北京 100021
Clinical characteristics and efficacy of second primary malignancies in hypopharyngeal carcinoma: an analysis of 216 real‐world cases
Luo Xi1, Wu Runye1, Liu Shaoyan2, Wang Xiaolei2, Ni Xiaoguang3, Zhang Ye1, Huang Xiaodong1, Wang Kai1, Chen Xuesong1, Wang Jingbo1, Zhang Jianghu1, Qu Yuan1, Luo Jingwei1, Yi Junlin1
1Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;
2Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;
3Department of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      背景资料
摘要 目的 在真实世界研究中探索下咽合并第二原发性肿瘤的发生率、临床特征及预后情况。方法 回顾性分析2010年至2018年中国医学科学院肿瘤医院收治的594例初治下咽癌患者,分析其合并第二原发性肿瘤的发生率及临床特征,比较不同组别间的疗效差异。结果 中位随访时间66.9个月,594名初治下咽癌患者中,216例发生第二原发性肿瘤,总发生率为36.4%,其中22.2%(132/594)为同时性,14.1%(84/594)为异时性。上消化‐呼吸道黏膜为最常见累及部位。相比于不合并第二原发性肿瘤患者,同时性原位癌和异时性原位癌患者的5年总生存(OS)率分别为42.2%∶44.5%(P=0.958)、62.2%∶44.5%(P=0.240)。下咽合并同时性浸润性第二原发性肿瘤组的生存明显差于不合并第二原发性肿瘤组,5年OS率为27.2%∶44.5%(P=0.001);下咽合并异时性浸润性第二原发性肿瘤患者预后较好,5年OS为50.2%∶44.5%(P=0.587),但第二原发性肿瘤仍占全组死亡原因的42.5%。结论 下咽合并第二原发性肿瘤概率较高,合并食管/胃原位癌以及异时性第二原发者不影响下咽癌患者的预后,而合并同时性第二原发者显著影响患者预后。第二原发性肿瘤的发生为合并异时性第二原发者的主要死亡原因之一。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
罗希
吴润叶
刘绍严
王晓雷
倪晓光
张烨
黄晓东
王凯
陈雪松
王静波
张江鹄
曲媛
罗京伟
易俊林
关键词 下咽肿瘤肿瘤,继发原发性放射疗法预后    
AbstractObjective To evaluate the incidence, clinical characteristics and prognosis of second primary malignancies (SPMs) among patients with hypopharyngeal carcinoma (HPC) in real‐world analysis. Methods A total of 594 HPC patients admitted to Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College from 2010 to 2018 were retrospectively analyzed.The incidence and clinical characteristics of HPC patients complicated with SPMs were analyzed. Clinical efficacy was compared among different groups. Results With a median follow‐up time of 66.9 months, SPMs were present in 36.4% (216/594) of HPC patients: 22.2% (132/594) were synchronous and 14.1% (84/594) were metachronous. The upper aerodigestive tract was the most common involved region. Compared with patients without SPMs, patients with synchronous and metachronous carcinoma in situ had similar 5‐year overall survival (OS) of 42.2% vs. 44.5% (P=0.958) and 62.2% vs. 44.5% (P=0.240), respectively. Patients with synchronous invasive SPMs had a worse 5‐year OS of 27.2% vs. 44.5% in their counterparts without SPMs (P=0.001). Patients with metachronous invasive SPMs had similar 5‐year OS of 50.2% vs. 44.5% in their counterparts without SPMs (P=0.587). SPMs accounted for 42.5% of total death in metachronous invasive SPMs group. Conclusions Patients with HPC have a high probability of developing SPMs. Moreover, the incidence of complicated with esophageal/gastric carcinoma in situ or metachronous SPMs exerts no effect on prognosis, while the occurrence of synchronous SPMs significantly affectes the prognosis of patients. However, the incidence of SPMs is still one of the main death causes in metachronous invasive SPMs group.
Key wordsHypopharyngeal carcinoma    Neoplasms,second primary    Radiotherapy    Prognosis   
收稿日期: 2021-11-03     
基金资助:国家重点研发计划(2017YFC0107500)
通讯作者: 易俊林,Email:yijunlin1969@163.com   
引用本文:   
罗希,吴润叶,刘绍严等. 下咽合并第二原发性肿瘤的临床特征及疗效分析:216例真实世界研究[J]. 中华放射肿瘤学杂志, 2023, 32(3): 194-200.
Luo Xi,Wu Runye,Liu Shaoyan et al. Clinical characteristics and efficacy of second primary malignancies in hypopharyngeal carcinoma: an analysis of 216 real‐world cases[J]. Chinese Journal of Radiation Oncology, 2023, 32(3): 194-200.
链接本文:  
http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.cn113030-20211103-00451     或     http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2023/V32/I3/194
京公网安备11010502022167号
版权所有 © 2010《中华放射肿瘤学杂志》编辑部
地址:北京朝阳区潘学园南里17号 中国医学科学院肿瘤医院(100021)
电话:010-67700737,87788294 Email: cjron@cmaph.org
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:Support@magtech.com.cn